AI Science Tracker

Beijing Anzhen Hospital, Capital Medical University

1 discovery from 2024

Discoveries

Machine-learning-guided proteomics identifies APOC3, RAB39A and KNG1 for plaque-rupture classification in acute coronary syndrome

In an acute-coronary-syndrome derivation cohort matched for plaque rupture (PR) versus intact fibrous cap (IFC), quantitative mass spectrometry measured 1,121 plasma proteins. Five machine-learning algorithms screened candidate proteins; APOC3, RAB39A and KNG1 were then significantly different between PR and IFC in an independent 85-patient cohort using ELISA. The three proteins discriminated plaque rupture better than the study’s conventional biomarkers and risk factors, suggesting a candidate biomarker panel for identifying PR among ACS patients.

Technology: Unbiased machine-learning feature screening of quantitative mass-spectrometry plasma proteomics using five algorithms

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: retrospective or benchmark
  • Tested: In an acute-coronary-syndrome derivation cohort matched for plaque rupture (PR) versus intact fibrous cap (IFC), quantitative mass spectrometry measured 1,121 plasma proteins.
  • Still unknown: This was a small matched derivation cohort (110 ACS patients) and an 85-patient validation cohort, not prospective outcome prediction or a clinical-impact trial. The proteins are candidate diagnostic markers; the study does not show that using them improves management or outcomes, nor establish causal roles in plaque rupture. The publisher reports electronic publication 2024-08-06 and issue date 2024-09-15; the record uses online-first date.
  • AI role: The ML algorithms selected nine candidate proteins from the proteomic measurements; the study subsequently tested candidates in an independent ACS cohort and confirmed three analytes—APOC3, RAB39A and KNG1—as significantly different in plaque-rupture versus intact-cap groups. ELISA provided the independent protein validation. The AI-enabled result is this prioritized, externally tested three-protein panel for a specific plaque phenotype.

Evidence sources: https://www.sciencedirect.com/science/article/pii/S0009898124021570

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: at percentile 51 of works of the same type, year and subfield (OpenAlex work metrics, 1 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.